LICENSE AGREEMENT BETWEENLicense Agreement • August 9th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 9th, 2016 Company Industry JurisdictionThis agreement ("Agreement") is made by and between Annapurna Therapeutics Limited, an Irish corporation having an address at 9 Upper Pembroke Street, Dublin 2 ("LICENSEE") and Cornell University (“Cornell”) as represented by its Center for Technology Licensing ("CTL") at Cornell University at 395 Pine Tree Road, Ithaca, NY 14850.
LICENSE AGREEMENT BETWEENLicense Agreement • August 9th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 9th, 2016 Company Industry JurisdictionThis agreement ("Agreement") is made by and between Annapurna Therapeutics Limited, an Irish corporation having an address at 9 Upper Pembroke Street, Dublin 2 ("LICENSEE") and Cornell University (“Cornell”) as represented by its Center for Technology Licensing ("CTL") at Cornell University at 395 Pine Tree Road, Ithaca, NY 14850.
ContractLicense Agreement • August 9th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 9th, 2016 Company Industry Jurisdiction[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.